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ReBACKGROUND Older women presenting with ST-segment elevation myocardial infarction (STEMI) are less likely to
receive revascularization and have worse outcomes relative to their male counterparts.
OBJECTIVES This study sought to determine temporal trends and sex differences in revascularization and in-hospital
outcomes of younger patients with STEMI.
METHODS We used the 2004 to 2011 Nationwide Inpatient Sample databases to identify all patients age 18 to
59 years hospitalized with STEMI. Temporal trends and sex differences in revascularization strategies, in-hospital
mortality, and length of stay were analyzed.
RESULTS From 2004 to 2011, of 1,363,492 younger adults (age <60 years) with acute myocardial infarction, 632,930
(46.4%) had STEMI. Younger women with acute myocardial infarction were less likely than men to present with STEMI
(adjusted odds ratio [OR]: 0.74; 95% conﬁdence interval [CI]: 0.73 to 0.75). Younger women with STEMI were less likely
to receive reperfusion as compared with younger men (percutaneous coronary intervention adjusted OR: 0.74; 95% CI:
0.73 to 0.75) (coronary artery bypass grafting adjusted OR: 0.61; 95% CI: 0.60 to 0.62) (thrombolysis adjusted OR:
0.80; 95% CI: 0.78 to 0.82). From 2004 to 2011, use of percutaneous coronary intervention for STEMI increased in both
younger men (63.9% to 84.8%; ptrend < 0.001) and women (53.6% to 77.7%; ptrend < 0.001). In-hospital mortality was
signiﬁcantly higher in younger women compared with men (4.5% vs. 3.0%; adjusted OR: 1.11; 95% CI: 1.07 to 1.15). There
was an increasing trend in risk-adjusted in-hospital mortality in both younger men and women during the study period.
Length of stay decreased in both younger men and women (ptrend < 0.001).
CONCLUSIONS Younger women are less likely to receive revascularization for STEMI and have higher in-hospital
mortality as compared with younger men. Use of percutaneous coronary intervention for STEMI and in-hospital
mortality have increased, whereas length of stay has decreased in both sexes over the past several years.
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1962D espite a signiﬁcant decrease indeath rates associated with cardio-vascular diseases in the United
States over the last decade, the burden
remains high with 1 in every 3 deaths
still attributed to cardiovascular disease (1).
Acute myocardial infarction (AMI) con-
tinues to be a major cause of morbidity and
mortality and affects a substantial propor-
tion of the population (2–4). Recent data sug-
gest that the hospitalization rates for AMI in
younger patients have remained unchanged
in the past decade (5). However, there is a
paucity of data on the contemporary trends
and sex differences in reperfusion and out-
comes in younger patients with ST-segment
elevation myocardial infarction (STEMI).SEE PAGE 1973In this study, we describe the temporal
trends in reperfusion (thrombolysis, percutaneous
coronary intervention [PCI], and coronary artery
bypass grafting [CABG]) and in-hospital outcomes of
STEMI in younger adults (18 to 59 years of age) in
the United States. It has been previously reported
that women are less likely than men to undergo
revascularization or invasive procedures for AMI
(6,7). Hence, we analyzed the sex-stratiﬁed trends
in reperfusion to further study the temporal changes
over the study period.
METHODS
DATA SOURCE. We analyzed data from the Nation-
wide Inpatient Sample (NIS) ﬁles from 2004 to 2011,
which contains data on inpatient hospital stays from
states (n ¼ 46 in 2011) participating in the Healthcare
Cost and Utilization Project. Each year the NIS pro-
vides data on roughly 8 million hospitalizations from
about 1,000 hospitals. The NIS is designed to
approximate a 20% sample of U.S. community hos-
pitals, deﬁned as “all non-federal, short-term, gen-
eral, and other specialty hospitals, excluding hospital
units of institutions,” representing more than 95% ofthe American College of Cardiology (guest editor; associate editor
mmittee), Slack Publications (chief medical editor, Cardiology
s); is a deputy editor of Clinical Cardiology; has received research f
bb, Eisai, Ethicon, Forest Laboratories, Ischemix, Medtronic, Pﬁze
tor for Biotronik and St. Jude Medical; is a trustee for the Ame
earch with FlowCo, PLx Pharma, and Takeda. All other authors ha
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received May 5, 2015; revised manuscript received August 6, 20the U.S. population. Criteria used for stratiﬁed sam-
pling of hospitals into the NIS include ownership,
bed size, teaching status, urban/rural location, and
U.S. region. All discharges from sampled hospitals are
included in the NIS database. The NIS is an all-payer
database that covers all patients, including those
covered by Medicare, Medicaid, or private insurance,
and those who are uninsured. Inpatient stay records
in the NIS include clinical and resource use infor-
mation available from discharge abstracts derived
from state-mandated hospital discharge reports.
Discharge weights provided by the NIS allow extrap-
olation to calculate expected national hospitalization
rates (8).
STUDY POPULATION. From 2004 to 2011, a total of
63,911,033 hospital records were included in the NIS,
corresponding to a national estimate of 313,736,891
hospital discharges in the United States. We used
the International Classiﬁcation of Diseases-Ninth
Edition-Clinical Modiﬁcation (ICD-9-CM) codes 410.x1
to identify all patients 18 to 59 years of age with the
principal diagnosis of AMI (n ¼ 1,588,206). We chose
the principal diagnosis because it is considered the
primary reason for hospital admission. We excluded
hospitalizations with missing data on patient age,
sex, length of stay (LOS), or in-hospital death
(n ¼ 947). We also excluded discharges in which
patients were admitted and discharged alive on the
same day (n ¼ 41,746). Lastly, we excluded discharges
in which patients were hospitalized from other hos-
pitals (n ¼ 182,020) to avoid duplication of records,
leaving a cohort of 1,363,492 patients with AMI.
Patients with the principal diagnosis of STEMI were
then identiﬁed using ICD-9-CM codes 410.11 to
410.61, 410.81, and 410.91 and comprised our ﬁnal
study cohort (n ¼ 632,930 [46.4% of all AMI]). ICD-
9-CM codes were also used to identify patients who
underwent coronary angiography (88.55, 88.56, 37.22,
37.23), thrombolysis (99.10, V45.88), PCI (00.66,
36.01, 36.02, 36.05, 36.06, 37.07), or CABG (36.1x).
Because primary PCI is the treatment of choice for
STEMI, we also determined the proportion of patients
who received PCI on the day of admission.), Population Health Research Institute (clinical trial
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1963OUTCOMES MEASURED. We initially studied the
overall and age group–speciﬁc trends in proportion of
STEMI in younger men and women with AMI.
We then examined the trends in thrombolysis, PCI,
and CABG in younger men and women with STEMI.
Our primary outcome of interest was all-cause, in-
hospital mortality, deﬁned as “died” during the hos-
pitalization encounter in the NIS database. The
average LOS was used as a secondary outcome. We
analyzed the overall and age group–speciﬁc trends in
in-hospital mortality and LOS in younger men and
women with STEMI. We also compared differences in
proportion of STEMI, use of thrombolysis/PCI/CABG
for STEMI, in-hospital mortality, and LOS among
younger men and women.
PATIENT AND HOSPITAL CHARACTERISTICS. Baseline
patient characteristics included were demographics
(age [stratiﬁed into subgroups of 18 to 29, 30 to 39, 40
to 49, and 50 to 59 years] and race/ethnicity), primary
expected payer, weekday versus weekend admission,
median household income for patient’s ZIP code,
29 Elixhauser comorbidities as deﬁned by the Agency
for Healthcare Research and Quality, and other clini-
cally relevant comorbidities (smoking, dyslipidemia,
known coronary artery disease, family history of
coronary artery disease, prior MI, prior PCI, prior
CABG, carotid artery disease, and atrial ﬁbrillation). A
list of ICD-9-CM and Clinical Classiﬁcations Software
codes used to identify comorbidities is provided in
the Online Table 1. We also included hospital-level
variables, such as teaching status, bed size (small,
medium, and large), hospital region (Northeast,
Midwest, South, and West), and location (rural or
urban).
STATISTICAL ANALYSIS. Weighted data were used
for all statistical analyses. For trend analysis, we used
the Cochrane-Armitage test for categorical variables
and linear regression for continuous variables. For
descriptive analyses, patient demographics, comor-
bidities, hospital characteristics, in-hospital pro-
cedures/treatments, and in-hospital outcomes were
compared among men and women using Pearson
chi-square test for categorical variables and Student
t test for continuous variables.
To determine the associations of sex with treatment
choice and outcomes (in-hospital mortality, LOS),
multivariable logistic or linear regression models were
constructed using generalized estimating equations
with exchangeable working correlation matrix. This
was done to account for clustering of outcomes within
hospitals. Variables included in the regression model
were age, primary expected payer, weekday versus
weekend admission, 29 Elixhauser comorbidities,other clinically relevant comorbidities (smoking,
dyslipidemia, known coronary artery disease, family
history of coronary artery disease, prior MI, prior
PCI, prior CABG, carotid artery disease, and atrial
ﬁbrillation), and hospital characteristics (region, bed
size, location, and teaching status). Race/ethnicity
was missing in 23.6% of the study population and
was therefore not included in the model. For in-
hospital mortality, after adjusting for the previously
mentioned covariates, we further adjusted for PCI
(on Day 0) to determine if differences in treatment
can explain the difference in mortality between men
and women. Risk-adjusted mortality per year was
calculated as described previously (9). For trend
analyses, we included the independent variable
“year” as a continuous variable in the regression
model to obtain unadjusted and adjusted odds ratio
(OR) per year. This approach has been used in pre-
vious studies (10). For LOS we used multivariable
linear regression analysis adjusting for all the pre-
viously mentioned variables. Because LOS had a
positively skewed distribution, we used log trans-
formation of LOS as the dependent variable.
Statistical analysis was performed using IBM SPSS
Statistics 20.0 (IBM Corp., Armonk, New York). All
p values were 2-sided with a signiﬁcance threshold
of p < 0.05. Categorical variables are expressed as
percentage and continuous variables as mean  SD.
OR and 95% conﬁdence interval (CI) are used to
report the results of logistic regression.
RESULTS
BASELINE CHARACTERISTICS. From 2004 to 2011,
we identiﬁed 632,930 patients (77.5% men, 22.5%
women) age 18 to 59 years who were hospitalized
with a primary diagnosis of STEMI. Women were
slightly older than men (mean age, 50.3 vs. 50.2 years)
and more likely to have carotid artery disease, deﬁ-
ciency anemias, rheumatoid arthritis/other collagen
vascular diseases, congestive heart failure, chronic
pulmonary diseases, depression, diabetes mellitus,
hypertension, hypothyroidism, ﬂuid and electrolyte
disorders, obesity, paralysis, peripheral vascular dis-
ease, and chronic renal failure (p < 0.001 for all)
(Table 1). Women were less likely to be smokers and
less likely to have dyslipidemia, known coronary
artery disease, family history of coronary artery dis-
ease, prior MI, prior PCI, prior CABG, and atrial
ﬁbrillation (p < 0.001 for all).
There was an increasing trend in smoking, dysli-
pidemia, coronary artery disease, prior MI, prior PCI,
diabetes mellitus, hypertension, obesity, peripheral
vascular disease, and chronic renal failure in both
TABLE 1 Baseline Demographics, Hospital Characteristics, and Comorbidities in
Younger Patients With ST-Segment Elevation Myocardial Infarction
Total Men Women p Value
Number of cases (weighted) 632,930 490,855 142,075
Age, yrs 50.2  6.8 50.2  6.8 50.3  6.9 <0.001
Age groups <0.001
18–29 yrs 5,659 (0.9) 4,446 (0.9) 1,213 (0.9)
30–39 yrs 43,197 (6.8) 33,692 (6.9) 9,505 (6.7)
40–49 yrs 200,852 (31.7) 156,299 (31.8) 44,553 (31.4)
50–59 yrs 383,222 (60.5) 296,418 (60.4) 86,804 (61.1)
Race <0.001
White 361,010 (74.7) 282,509 (75.3) 78,501 (72.5)
African American 47,998 (9.9) 31,622 (8.4) 16,376 (15.1)
Hispanic 41,013 (8.5) 32,799 (8.7) 8,214 (7.6)
Asian or Paciﬁc Islander 11,081 (2.3) 9,578 (2.6) 1,503 (1.4)
Native American 3,251 (0.7) 2,620 (0.7) 631 (0.6)
Other 19,182 (4.0) 16,119 (4.3) 3,063 (2.8)
Primary expected payer <0.001
Medicare 53,868 (8.5) 38,098 (7.8) 15,770 (11.1)
Medicaid 66,587 (10.6) 44,439 (9.1) 22,148 (15.6)
Private insurance 371,371 (58.8) 295,428 (60.4) 75,943 (53.6)
Self-pay 95,616 (15.2) 75,643 (15.5) 19,973 (14.1)
No charge 8,804 (1.4) 6,937 (1.4) 1,867 (1.3)
Other 34,801 (5.5) 28,879 (5.9) 5,922 (4.2)
Median household income <0.001
0 to 25th percentile 170,811 (27.7) 126,340 (26.4) 44,471 (32.1)
26th to 50th percentile 165,908 (26.9) 126,810 (26.5) 39,098 (28.2)
51st to 75th percentile 152,067 (24.7) 119,896 (25.1) 32,171 (23.2)
76th to 100th percentile 127,477 (20.7) 104,719 (21.9) 22,758 (16.4)
Weekend admission 181,757 (28.7) 141,875 (28.9) 39,882 (28.1) <0.001
Hospital characteristics
Region <0.001
Northeast 96,086 (15.2) 75,543 (15.4) 20,543 (14.5)
Midwest 158,191 (25.0) 121,751 (24.8) 36,640 (25.6)
South 264,815 (41.8) 201,985 (41.1) 62,380 (44.2)
West 113,838 (18.0) 91,575 (18.7) 22,263 (15.7)
Bed size* <0.001
Small 45,714 (7.2) 34,672 (7.1) 11,042 (7.8)
Medium 137,297 (21.9) 105,870 (21.7) 31,427 (22.3)
Large 445,287 (70.9) 346,741 (71.2) 98,546 (69.9)
Urban location 576,046 (91.7) 448,498 (92.0) 127,548 (90.4) <0.001
Teaching hospital 305,129 (48.6) 237,564 (48.8) 67,565 (47.9) <0.001
Continued on the next page
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1964younger men and women over the study period
(Online Tables 2 and 3).
TRENDS IN PROPORTION OF STEMI. In the overall
AMI population, younger women were less likely
than men to present with a STEMI (38.4% vs. 49.4%,
p < 0.001; adjusted OR: 0.74; 95% CI: 0.73 to 0.75;
p < 0.001). The proportion of STEMI decreased in
both younger men and women during the study
period (54.0% in 2004 to 45.2% in 2011 in men,
and 44.6% in 2004 to 34.7% in 2011 in women,
ptrend < 0.001). Although there was a decrease in the
absolute number of STEMIs from 2004 to 2011 in
younger men (61,304 to 58,299; ptrend ¼ 0.004) andwomen (18,354 to 17,330; ptrend < 0.001), the decrease
in proportion of STEMI was mainly caused by a
substantial increase in the absolute number of non-ST-
segment elevation myocardial infarctions (NSTEMIs)
over the study period (younger men, 52,265 to 70,737;
ptrend < 0.001; younger women, 22,827 to 32,589;
ptrend < 0.001). Similar ﬁndings were observed across
all age-stratiﬁed subgroups (Table 2).
TRENDS IN CORONARY ANGIOGRAPHY IN YOUNGER
PATIENTS WITH STEMI. Younger women with STEMI
were less likely to undergo coronary angiography as
compared with younger men (82.2% vs. 86.5%; un-
adjusted OR: 0.69; 95% CI: 0.68 to 0.70; adjusted OR:
0.94; 95% CI: 0.92 to 0.96; p < 0.001). From 2004 to
2011, there was an increasing trend in use of coronary
angiography in both younger men (79.3% to 90.4%;
unadjusted OR per year: 1.15; 95% CI: 1.14 to 1.15;
adjusted OR per year: 1.12; 95% CI: 1.11 to 1.12;
ptrend < 0.001) and younger women (68.3% to 79.2%;
unadjusted OR per year: 1.09; 95% CI: 1.09 to 1.10;
adjusted OR per year: 1.08; 95% CI: 1.07 to 1.08;
ptrend < 0.001) (Figure 1).
TRENDS IN REPERFUSION FOR STEMI. Younger
women were less likely to receive reperfusion for
STEMI as compared with younger men in the overall
cohort. PCI was performed in 68.4% of women versus
76.7% of men (unadjusted OR: 0.66; 95% CI: 0.65
to 0.67; adjusted OR: 0.74; 95% CI: 0.73 to 0.75;
p < 0.001). PCI on Day 0 was done in 49.6% of women
versus 57.7% of men (unadjusted OR: 0.72; 95% CI:
0.71 to 0.73; adjusted OR: 0.75; 95% CI: 0.75 to 0.76;
p < 0.001). Thrombolysis was done in 4.2% of women
and 4.5% of men (unadjusted OR: 0.91; 95% CI: 0.89
to 0.94; adjusted OR: 0.80; 95% CI: 0.78 to 0.82;
p < 0.001). CABG was done in 6.1% of women versus
8% of men in the overall cohort (unadjusted OR: 0.75;
95% CI: 0.73 to 0.76; adjusted OR: 0.61; 95% CI: 0.60
to 0.62; p < 0.001).
There was an increasing trend in use of PCI for
STEMI in both younger men and women during the
study period (from 63.9% in 2004 to 84.8% in 2011 in
men, and 53.6% in 2004 to 77.7% in 2011 in women;
ptrend < 0.001) (Figure 2, Table 3). Similar trends were
observed in the use of PCI on Day 0 in both groups
(41.9% in 2004 to 71.2% in 2011 in men, and 33.0% in
2004 to 63.0% in 2011 in women; ptrend < 0.001). Use
of CABG decreased in both groups (9.2% in 2004 to
6.3% in 2011 in men, and 7.0% in 2004 to 5.8% in
2011 in women; ptrend < 0.001) (Figure 2, Table 3).
PCI USEWITH INCREASING NUMBER OF COMORBIDITIES.
To study the inﬂuence of baseline, coded comorbid-
ities on PCI use rates, we divided younger men and
women into 4 groups on the basis of the number of
TABLE 1 Continued
Total Men Women p Value
Comorbidities†
Smoking 343,040 (54.2) 267,374 (54.5) 75,666 (53.3) <0.001
Dyslipidemia 353,633 (55.9) 280,541 (57.2) 73,092 (51.4) <0.001
Coronary artery disease 509,387 (80.5) 410,597 (81.8) 107,790 (75.9) <0.001
Family history of coronary
artery disease
83,262 (13.2) 65,860 (13.4) 17,402 (12.2) <0.001
Prior myocardial infarction 43,426 (6.9) 35,356 (7.2) 8,070 (5.7) <0.001
Prior percutaneous coronary
intervention
58,242 (9.2) 47,780 (9.7) 10,462 (7.4) <0.001
Prior coronary artery bypass
grafting
13,281 (2.1) 10,497 (2.1) 2,784 (2.0) <0.001
Carotid artery disease 2,229 (0.4) 1,553 (0.3) 676 (0.5) <0.001
Atrial ﬁbrillation 29,118 (4.6) 23,483 (4.8) 5,635 (4.0) <0.001
Acquired immune deﬁciency
syndrome
1,964 (0.3) 1,735 (0.4) 229 (0.2) <0.001
Alcohol abuse 30,207 (4.8) 27,002 (5.5) 3,205 (2.3) <0.001
Deﬁciency anemia 34,974 (5.5) 21,121 (4.3) 13,853 (9.8) <0.001
Rheumatoid arthritis/collagen
vascular diseases
8,046 (1.3) 3,532 (0.7) 4,514 (3.2) <0.001
Chronic blood loss anemia 3,078 (0.5) 1,670 (0.3) 1,408 (1.0) <0.001
Congestive heart failure 75,332 (11.9) 54,881 (11.2) 20,451 (14.4) <0.001
Chronic pulmonary disease 73,943 (11.7) 49,317 (10.0) 24,626 (17.3) <0.001
Coagulopathy 15,810 (2.5) 12,208 (2.5) 3,602 (2.5) 0.31
Depression 30,893 (4.9) 17,926 (3.7) 12,967 (9.1) <0.001
Diabetes mellitus
(uncomplicated)
134,466 (21.2) 96,563 (19.7) 37,903 (26.7) <0.001
Diabetes mellitus
(with chronic complications)
16,590 (2.6) 10,340 (2.1) 6,250 (4.4) <0.001
Drug abuse 27,487 (4.3) 22,365 (4.6) 5,122 (3.6) <0.001
Hypertension 328,944 (52.0) 250,891 (51.1) 78,053 (54.9) <0.001
Hypothyroidism 21,286 (3.4) 9,894 (2.0) 11,392 (8.0) <0.001
Liver disease 6,900 (1.1) 5,501 (1.1) 1,399 (1.0) <0.001
Lymphoma 1,357 (0.2) 986 (0.2) 371 (0.3) <0.001
Fluid and electrolyte disorder 70,582 (11.2) 49,478 (10.1) 21,104 (14.9) <0.001
Metastatic cancer 1,883 (0.3) 1,125 (0.2) 758 (0.5) <0.001
Other neurological disorders 16,658 (2.6) 11,502 (2.3) 5,156 (3.6) <0.001
Obesity 84,073 (13.3) 57,513 (11.7) 26,560 (18.7) <0.001
Paralysis 3,749 (0.6) 2,596 (0.5) 1,153 (0.8) <0.001
Peripheral vascular disease 26,498 (4.2) 18,807 (3.8) 7,691 (5.4) <0.001
Psychoses 11,746 (1.9) 7,901 (1.6) 3,845 (2.7) <0.001
Pulmonary circulation disorders 247 (0.04) 178 (0.04) 69 (0.05) 0.04
Renal failure (chronic) 23,066 (3.6) 16,352 (3.3) 6,714 (4.7) <0.001
Solid tumor without metastasis 2,470 (0.4) 1,771 (0.4) 699 (0.5) <0.001
Peptic ulcer disease
(nonbleeding)
103 (0.02) 93 (0.02) 10 (0.08) 0.002
Valvular disease 355 (0.1) 233 (0.05) 122 (0.1) <0.001
Weight loss 4,822 (0.8) 3,395 (0.7) 1,487 (1.0) <0.001
Values are mean  SD or n (%). *Bed size categories are speciﬁc to hospital location and teaching. †Comorbidities
(including the 29 Elixhauser comorbidities) were extracted from the database using International Classiﬁcation of
Diseases-Ninth Edition-Clinical Modiﬁcation Diagnosis or Clinical Classiﬁcation Software codes.
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1965Elixhauser comorbidities (0, 1, 2, and 3þ). Younger
women were less likely to receive revascularization
in all groups, and the revascularization disparity be-
tween younger men and women was greatest in pa-
tients with zero comorbidities (9.3%) and least in
patients with 3þ comorbidities (3.3%). The interac-
tion between sex and number of comorbidities was
signiﬁcant in the multivariable model (p interaction
<0.001) (Figure 3).
TRENDS IN OUTCOMES. Our primary outcome of
interest for this study was in-hospital mortality.
Younger women had higher in-hospital mortality
compared with younger men in the overall study pop-
ulation (4.5% vs. 3.0%; unadjusted OR: 1.45; 95% CI:
1.45 to 1.53; adjusted OR: 1.11; 95% CI: 1.07 to 1.15;
p < 0.001). Women had 11% higher overall in-hospital
mortality compared with men irrespective of revascu-
larization status (adjusted ORrevascularization: 1.11; 95%
CI: 1.06 to 1.17; p < 0.001; adjusted ORno revascularization:
1.11; 95% CI: 1.07 to 1.15; p < 0.001). Trend analyses
revealed a signiﬁcant increase in risk-adjusted in-hos-
pital mortality from 2004 to 2011 in both younger men
and women, and in all subgroups (Figure 4A, Table 4,
Online Table 4).
Women had longer average LOS than men in the
overall study population (4.35 vs. 4.00 days; unad-
justed parameter estimate, 1.05; 95% CI: 1.04 to 1.05;
adjusted parameter estimate, 1.04; 95% CI: 1.03 to
1.06; p < 0.001). Average LOS decreased in both men
and women over the study period (4.13 days in 2004
to 3.86 days in 2011 in men, and 4.59 days in 2004 to
4.24 days in 2011 in women; ptrend < 0.001) (Figure 4B,
Online Table 5).
DISCUSSION
In this large, multi-institutional, population-based
observational study of younger adults in the United
States, we observed that among patients with AMI,
women were less likely than men to present with
STEMI. There was a temporal decline in the proportion
of STEMI in both sexes as a result of a small decrease in
the absolute number of STEMIs, but mainly because of
a substantial increase in the absolute number of
NSTEMIs. Although there was an increase in use of PCI
in both younger men and women with STEMI, women
were less likely than men to undergo PCI. Younger
women with STEMI had higher in-hospital mortality
and longer average LOS than younger men. There was
a temporal increase in risk-adjusted in-hospital mor-
tality and decrease in LOS in both younger men and
women (Central Illustration).
Using data from the NIS databases from 2001
to 2010, Gupta et al. (5) recently reported thathospitalization rates for AMI (both STEMI and
NSTEMI) have remained unchanged over the last
decade in younger adults age 30 to 54 years in the
United States. However, this study did not explore
the differential trends in STEMI and NSTEMI in
younger adults or trends and sex differences in
TABLE 2 Temporal Trends in Proportion of ST-Segment Elevation Myocardial Infarction Among Younger Patients With
Acute Myocardial Infarction
Overall
(%)
2004
(%)
2005
(%)
2006
(%)
2007
(%)
2008
(%)
2009
(%)
2010
(%)
2011
(%) ptrend
Overall
Men 49.4 54.0 52.5 52.4 50.7 49.1 46.9 45.9 45.2 <0.001
Women 38.4 44.6 43.2 42.3 38.7 37.6 34.2 34.8 34.7 <0.001
Age 18–29 yrs
Men 48.9 49.8 50.1 49.9 51.8 48.9 52.3 42.3 45.6 0.001
Women 40.6 48.5 43.3 40.4 41.7 40.0 39.8 37.7 36.2 <0.001
Age 30–39 yrs
Men 51.3 56.2 54.6 52.9 51.5 50.7 49.5 48.3 47.9 <0.001
Women 41.1 46.4 45.8 42.6 41.2 38.6 38.0 38.4 39.3 <0.001
Age 40–49 yrs
Men 51.5 56.7 53.8 54.6 52.9 50.8 49.0 47.9 47.0 <0.001
Women 40.3 45.0 44.5 44.5 41.6 39.5 36.8 35.9 36.5 <0.001
Age 50–59 yrs
Men 48.1 52.4 51.5 51.2 49.4 48.0 45.5 44.8 44.1 <0.001
Women 37.3 44.1 42.3 41.1 37.1 36.5 32.6 33.8 33.5 <0.001
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1966reperfusion strategies. Our current ﬁndings of
decline in the proportion of STEMI in younger men
and women, coupled with the observations of Gupta
et al. (5), suggest that the proportion (and absolute
number) of NSTEMI has increased in recent years in
younger U.S. adults, perhaps caused in part by more
widespread use of sensitive cardiac biomarker as-
says resulting in more cases of unstable angina be-
ing classiﬁed as NSTEMI (11). Nonetheless, we did
observe a small decline in the absolute number of
STEMIs in both younger men and women over the
study period. Furthermore, in the current study,FIGURE 1 Temporal Trends in Coronary Angiography in Younger Me
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Co
ro
na
ry
 A
ng
io
gr
ap
hy
 (%
)
2004 2005 2006 2007
Men (Ptrend<0.001)
Women (Ptrend<0.001)
ptrend < 0.001 for both men and women. STEMI ¼ ST-segment elevatiowe also examined temporal trends and sex differ-
ences in revascularization for STEMI in younger
adults. Our analysis showed that although there
have been temporal increases in revascularization
rates for STEMI both in younger men and women,
there are persistent sex-based differences in the
use of revascularization therapies and associated
in-hospital outcomes among younger adults with
STEMI.
Our ﬁndings of lower STEMI rates in younger
women as compared with men parallel those of pre-
vious studies (12,13). Rates of STEMI in the generaln and Women With STEMI
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n myocardial infarction.
FIGURE 2 Temporal Trends in Use of Thrombolysis, PCI, and CABG Among Younger Men and Women With STEMI
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TABLE 3 Temporal Trends in Revascularization in Younger Patients With ST-Segment Elevation Myocardial Infarction
Overall
(%)
2004
(%)
2005
(%)
2006
(%)
2007
(%)
2008
(%)
2009
(%)
2010
(%)
2011
(%)
OR Per Year (95% CI)
Unadjusted Adjusted*
Thrombolysis
Men 4.5 5.2 4.7 4.2 3.1 3.0 5.7 5.1 5.3 1.02 (1.01–1.03) 1.03 (1.02–1.03)
Women 4.2 4.4 4.1 3.6 2.7 3.8 5.1 4.8 4.9 1.03 (1.02–1.05) 1.04 (1.03–1.05)
PCI
Men 76.7 63.9 69.2 73.7 76.6 79.6 82.2 83.7 84.8 1.18 (1.18–1.19) 1.19 (1.19–1.20)
Women 68.4 53.6 59.5 64.6 68.6 73.3 74.8 76.0 77.7 1.18 (1.17–1.18) 1.16 (1.15–1.17)
PCI Day 0
Men 57.7 41.9 46.3 52.6 54.3 59.5 66.8 69.4 71.2 1.20 (1.20–1.21) 1.21 (1.21–1.22)
Women 49.6 33.0 37.7 44.1 45.5 53.0 59.7 62.1 63.0 1.21 (1.20–1.21) 1.20 (1.19–1.21)
CABG
Men 8.0 9.2 8.8 8.5 7.8 8.2 8.1 6.9 6.3 0.95 (0.95–0.96) 0.91 (0.90–0.91)
Women 6.1 7.0 6.5 6.0 6.1 5.9 6.0 5.4 5.8 0.97 (0.96–0.98) 0.93 (0.92–0.94)
*Adjusted for demographics, hospital characteristics, and comorbidities.
CABG ¼ coronary artery bypass grafting; CI ¼ conﬁdence interval; OR ¼ odds ratio; PCI ¼ percutaneous coronary intervention.
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1968population have declined over the last several years,
as shown in numerous recent studies (4,14,15). Our
current study extends these ﬁndings to younger
adults between 18 and 59 years of age.
We observed that younger women with STEMI
were less likely to receive revascularization than
younger men. We also found that whereas the use of
thrombolysis and PCI increased over the years in both
men and women, the use of CABG decreased. Previ-
ous reports on the overall STEMI population have
also described similar ﬁndings (7,16,17). Results from
the recent prospective U.S. VIRGO (Variations inFIGURE 3 Differences in Use of PCI for STEMI
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AMI Patients) study showed that in young patients
age 18 to 55 years with STEMI who were eligible
for reperfusion, women were more likely to be
untreated than men (18).
A novel ﬁnding from our current study is the
narrowing of absolute differences in the use of
PCI for STEMI between younger men and women
with increasing number of baseline comorbidities
(Figure 3). Despite narrowing of the absolute differ-
ences, younger women were still less likely to receive
PCI for STEMI. Several reasons can be postulated toP<0.001
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FIGURE 4 Temporal Trends in Risk-Adjusted In-Hospital Mortality and Length of Stay
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1969explain these ﬁndings. Younger women with AMI are
less likely to have chest pain/discomfort and are
more likely to have atypical presentations (12,19).
It is plausible that this may lead to more delayed
presentation and underrecognition of STEMI at
initial medical contact, thus precluding acute reper-
fusion for STEMI. Lower revascularization rates
can also be explained, in part, because of higher
frequency of alternative etiologies, such as Takot-
subo (stress) cardiomyopathy, spontaneous coronary
artery dissection, and coronary vasospasm in younger
women. Another potential reason for lower use of
revascularization in women could be the almost
2-fold increased risk of bleeding as compared with
men (20,21). This potentially higher bleeding risk
can prevent women with atypical symptoms from
getting guideline-speciﬁc interventional therapies.
Excess early mortality after AMI in younger women
was ﬁrst described by Vaccarino et al. (22). They re-
ported that the younger the age, the greater the risk
of in-hospital mortality among women as compared
with men. Concordant with ﬁndings of previous
studies in the overall STEMI population (12,17,23), we
observed that younger women with STEMI had higher
risk-adjusted in-hospital mortality as compared with
younger men. In our study, the difference in mean
age at presentation between women and men was
very small. We did observe a higher prevalence of
comorbidities in younger women as compared with
men. In addition to lower use of revascularization,
another likely reason for higher in-hospital mortality
in younger women in STEMI could be the lower use of
adjunctive medical therapies as shown in previous
studies in the overall STEMI population (24–26).
Women with STEMI also experience treatment delays
post-hospital arrival with signiﬁcantly longer door-
to-electrocardiography, door-to-needle, and door-
to-balloon times (7,17,25). Of note, men are also
more likely than women to die before arrival to hos-
pital and this may possibly confound the excess in-
hospital mortality observed in women (26). Using
data from GWTG-CAD, Bangalore et al. (27) previously
reported that compared with men in the corre-
sponding age category, both younger and older
women with STEMI are less likely to receive
guideline-recommended medical therapy both at
admission and at hospital discharge. Interestingly,
there was a signiﬁcant interaction between age and
sex such that sex differences in STEMI performance
measures were greater in the younger cohort than
the older cohort. Data from the VIRGO study also
showed that young women with STEMI were more
likely to exceed in-hospital and transfer-time guide-
lines for PCI than men and more likely to exceeddoor-to-needle times. After multivariate adjustment,
sex was found to be an independent factor in ex-
ceeding reperfusion guidelines (18). Additional path-
ophysiological differences could contribute to the
higher mortality in younger women with STEMI.
Younger women have less extensive coronary artery
disease and they have lesser myocardial ischemic
preconditioning, resulting in a greater vulnerability
to acute ischemia (28). Contrary to the declining
mortality rates in the overall STEMI population
(14,16,29), there was a signiﬁcant temporal increase in
risk-adjusted in-hospital mortality in younger men
and women with STEMI. In contrast, Gupta et al. (5)
recently reported a decline in observed in-hospital
mortality in younger women but not in men with
AMI (STEMI and NSTEMI). Patients with NSTEMI
represent a lower-risk population and were not
included in our current study. Furthermore, we found
an increasing trend in “risk-adjusted” mortality.
Possible explanations for these adverse trends may
include increasing comorbidities, atypical symptoms,
delayed presentation, and unmeasured covariates.
TABLE 4 Temporal Trends in In-Hospital Mortality in Younger Patients With ST-Segment Elevation Myocardial Infarction
Overall
(%)
2004
(%)
2005
(%)
2006
(%)
2007
(%)
2008
(%)
2009
(%)
2010
(%)
2011
(%)
OR Per Year
(95% CI) ptrend
Overall
Men
Observed 3.0 3.0 3.0 2.8 3.0 3.3 3.0 3.1 3.2 1.01 (1.01–1.02) 0.006
Adjusted* — 2.7 2.9 2.7 3.0 3.4 3.3 3.3 3.4 1.05 (1.04–1.06) <0.001
Women
Observed 4.5 4.5 4.8 4.3 4.7 4.1 4.5 4.6 4.3 0.99 (0.98–1.01) 0.20
Adjusted* — 3.8 4.2 4.0 4.6 4.5 5.2 5.2 5.1 1.06 (1.05–1.07) <0.001
Age 18–29 yrs†
Men
Observed 3.0 4.4 2.6 2.3 4.5 3.7 3.2 0.0 2.8 0.92 (0.85–0.99) 0.03
Women
Observed 4.1 6.2 4.0 3.7 5.7 7.2 3.4 0.0 3.4 0.89 (0.79–0.99) 0.04
Age 30–39 yrs
Men
Observed 2.1 2.8 1.3 2.7 1.5 2.1 2.0 2.2 2.6 1.01 (0.97–1.04) 0.65
Adjusted* — 2.1 1.4 2.5 1.4 2.3 1.9 2.0 2.3 1.05 (1.01–1.10) 0.01
Women
Observed 3.6 3.2 5.4 2.9 3.8 1.7 6.4 1.6 3.8 0.98 (0.94–1.02) 0.37
Adjusted* — 2.6 4.0 2.4 3.0 3.4 6.9 2.2 4.3 1.05 (0.99–1.12) 0.09
Age 40–49 yrs
Men
Observed 2.4 2.2 2.1 2.4 2.5 2.5 2.4 2.5 2.3 1.02 (1.01–1.03) 0.04
Adjusted* — 1.9 1.9 2.5 2.7 2.7 2.8 2.8 2.4 1.06 (1.05–1.08) <0.001
Women
Observed 3.4 3.7 3.2 3.9 3.1 3.6 3.4 3.4 2.8 0.98 (0.96–1.00) 0.06
Adjusted* — 2.9 2.8 3.3 3.1 3.7 3.4 3.4 2.7 1.02 (0.99–1.04) 0.16
Age 50–59 yrs
Men
Observed 3.5 3.5 3.8 3.0 3.4 3.8 3.4 3.6 3.7 1.01 (0.99–1.02) 0.10
Adjusted* — 3.2 3.5 2.9 3.3 3.9 3.8 3.8 4.0 1.05 (1.04–1.06) <0.001
Women
Observed 5.1 5.1 5.6 4.6 5.6 4.6 4.8 5.6 5.1 1.00 (0.99–1.01) 0.98
Adjusted* — 4.2 4.7 4.3 5.3 5.0 5.6 6.4 6.3 1.08 (1.06–1.09) <0.001
PCI Day 0
Men
Observed 1.8 1.4 1.6 1.6 1.6 2.0 1.6 2.0 2.2 1.06 (1.04–1.07) <0.001
Adjusted* — 1.5 1.7 1.6 1.6 2.0 1.7 2.0 2.0 1.04 (1.03–1.06) <0.001
Women
Observed 2.4 1.7 2.7 1.7 2.1 2.3 2.8 2.7 2.9 1.07 (1.05–1.09) <0.001
Adjusted* — 1.7 2.5 1.6 2.3 2.4 2.7 2.8 2.9 1.09 (1.07–1.12) <0.001
PCI Day $1
Men
Observed 1.9 1.6 1.8 2.1 1.9 2.5 2.0 1.8 1.3 0.99 (0.98–1.02) 0.89
Adjusted* — 1.5 1.7 2.0 1.9 2.4 2.3 1.9 1.5 1.04 (1.02–1.07) <0.001
Women
Observed 2.5 1.7 2.4 2.7 2.4 2.4 3.9 1.7 2.8 1.04 (1.01–1.08) 0.02
Adjusted* — 1.6 2.4 2.6 2.4 2.4 3.8 1.9 3.2 1.08 (1.04–1.13) <0.001
*Adjusted for demographics, hospital characteristics, and comorbidities. †Risk adjusted mortality rates were not calculated for younger men and women age 18 to 29 years
because of small sample size and small number of events.
Abbreviations as in Table 3.
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1970However, further studies are needed to conﬁrm our
ﬁndings and determine the factors responsible for
the increasing trends in risk-adjusted mortality in
younger adults with STEMI.STUDY LIMITATIONS. Our data included only hospi-
talized patients with STEMI and did not account for
out-of-hospital deaths. Additionally, we could assess
only in-hospital outcomes and could not determine
PERSPECTIVES
COMPETENCY IN PATIENT CARE AND PROCEDURAL
SKILLS: Young men hospitalized with STEMI are more likely to
survive than young women with this condition.
COMPETENCY IN SYSTEMS-BASED PRACTICE: Despite
increased guideline-directed use of percutaneous coronary
intervention for patients with STEMI, young women are less
likely than young men to undergo timely revascularization.
TRANSLATIONAL OUTLOOK: Prospective studies are needed
to explore the factors responsible for sex-related disparities in
revascularization and outcomes in patients with STEMI and
evaluate strategies to address them.
CENTRAL ILLUSTRATION Differences and Temporal Trends in
Reperfusion and Outcomes After ST-Segment Elevation Myocardial
Infarction (STEMI) in Younger Men and Women
Women < Men
Women > Men
Women > Men
Differences                   Temporal Trends
Men         Women
Reperfusion
In-Hospital Mortality
Length of Stay
Younger Patients With STEMI
Khera, S. et al. J Am Coll Cardiol. 2015; 66(18):1961–72.
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1971whether post-discharge mortality was different be-
tween younger men and women to offset the sex
difference noted in in-hospital mortality. Patients in
the NIS database are not linked, and as a result wewere
not able to differentiate initial STEMIs from sub-
sequent STEMIs. Given the lack of angiographic
data, we were not able to account for extent and
severity of coronary artery disease, and the reason
why revascularization strategies were not used
in individual patients could not be ascertained.
There was no information available on important
STEMI performance measures, such as door-
to-electrocardiography, door-to-needle, and door-
to-balloon times. Given the abstracted nature of the
database, we relied on administrative data to obtain
information on comorbidities. Accuracy of certain
variables may be related to hospital coding practices
and the observed temporal increase in comorbidities
may be related to incentive-driven diagnosis-related
group upcoding. There were no data available on the
use of guideline-recommended adjunctive medical
therapies. Finally, residual measured or unmeasured
confounding could have accounted for some of our
ﬁndings.
CONCLUSIONS
Among younger adults with AMI, women were less
likely to present with STEMI as compared with men.
There was a decline in proportion of STEMI in both
younger men and women over the study period.
Younger women with STEMI were less likely to
receive revascularization and had higher unadjusted
and risk-adjusted in-hospital mortality as compared
with men. There was a temporal increase in the use of
revascularization in younger adults with STEMI. Risk-
adjusted in-hospital mortality increased, whereas
LOS decreased over the study period in both younger
men and women with STEMI. These data present a
persisting opportunity to improve national STEMI
care processes and outcomes, and to bridge the sex-
disparity in providing care to younger patients with
STEMI.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Deepak L. Bhatt, Brigham and Women’s Hospital
Heart & Vascular Center, Harvard Medical School, 75
Francis Street, Boston, Massachusetts 02115. E-mail:
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